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ABSTRACT
Objectives To determine how gene expression profiles 
in osteoarthritis joint tissues relate to patient phenotypes 
and whether molecular subtypes can be reproducibly 
captured by a molecular classification algorithm.
Methods We analysed RNA sequencing data from 
cartilage and synovium in 113 osteoarthritis patients, 
applying unsupervised clustering and Multi- Omics Factor 
Analysis to characterise transcriptional profiles. We 
tested the association of the molecularly defined patient 
subgroups with clinical characteristics from electronic 
health records.
Results We detected two patient subgroups in low- 
grade cartilage (showing no/minimal degeneration, 
cartilage normal/softening only), with differences 
associated with inflammation, extracellular matrix- 
related and cell adhesion pathways. The high- 
inflammation subgroup was associated with female 
sex (OR 4.12, p=0.0024) and prescription of proton 
pump inhibitors (OR 4.21, p=0.0040). We identified 
two independent patient subgroupings in osteoarthritis 
synovium: one related to inflammation and the other to 
extracellular matrix and cell adhesion processes. A seven- 
gene classifier including MMP13, APOD, MMP2, MMP1, 
CYTL1, IL6 and C15orf48 recapitulated the main axis of 
molecular heterogeneity in low- grade knee osteoarthritis 
cartilage (correlation ρ=−0.88, p<10−10) and was 
reproducible in an independent patient cohort (ρ=−0.85, 
p<10−10).
Conclusions These data support the reproducible 
stratification of osteoarthritis patients by molecular 
subtype and the exploration of new avenues for tailored 
treatments.
INTRODUCTION
Our understanding of the molecular mechanisms 
that underlie the observed epidemiological and 
clinical heterogeneity in osteoarthritis (OA) is 
incomplete. The accessibility of primary disease 
tissues at the point of joint replacement surgery 
provides the opportunity to stratify patients based 
on tissue- specific molecular profiles. Such stratifi-
cation may help provide mechanistic insights into 
the molecular processes underlying the disease and 
subsequently develop novel tailored treatments. 
By examining expression profiles in cartilage, two 
previous studies in small cohorts have identified 
two subgroups of patients: microarray data from 
23 patients suggested subgroups with gene expres-
sion differences related to inflammatory response, 
leucocyte activation, regulation of cytokine produc-
tion and chemokine activity1; RNA sequencing data 
from 44 patients also suggested two subgroups, but 
with differences related to oxidative stress, innate- 
immune responses, Wnt signalling and chemokine 
signalling rather than classical inflammation.2
Several questions emerge from these studies: 
Do molecular profiles in different disease- relevant 
tissues define the same patient subgroups? Is the 
molecular subgrouping associated with any clin-
ical characteristics? Is the molecular subgrouping 
Key messages
What is already known about this subject?
 ► Osteoarthritis (OA) is a disease with both 
clinical and molecular heterogeneity.
 ► However, it remains unclear whether 
molecular subgroupings of patients vary 
between joint tissue types, how they relate 
to clinical characteristics and whether they 
can be reproducibly captured by a molecular 
classification algorithm.
What does this study add?
 ► We carried out the first in- depth 
characterisation of molecular heterogeneity 
using patient synovium and cartilage in the 
largest cohort to date.
 ► We detected two patient subgroups based on 
low- grade (largely intact) OA cartilage, which 
were associated with sex and proton pump 
inhibitor prescription. Patient subgroups in 
synovium were associated with inflammation 
and, separately, extracellular matrix and cell 
adhesion, and were independent of the low- 
grade OA cartilage subgroups.
 ► A seven- gene classifier reproducibly 
recapitulated both the discrete assignment of 
knee low- grade OA cartilage subgroups and the 
main continuous spectrum of variation within 
the tissue.
How might this impact on clinical practice or 
future developments?
 ► These data demonstrate that molecular 
tissue profile in OA is associated with patient 
clinical characteristics, that this profile can be 
characterised using a limited panel of genes, 
and support the case for precision medicine 
approaches in OA.
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truly categorical or better reflected by a continuous spectrum 
of variation? Can a molecular classification algorithm repro-
ducibly recapitulate both categorical subgrouping and the main 
continuous spectrum of variation? Here, we examine these ques-
tions through genome- wide transcriptional profiling of multiple 
primary patient tissues (low- grade OA cartilage, high- grade OA 
cartilage and synovium), integrating information from electronic 
health records, and substantially increasing the cohort size and 
hence power (doubling the size of the discovery sample and 
almost tripling the total number of patients with genome- wide 
data compared with past studies).
MATERIAL AND METHODS
Patients
We analysed tissue samples from 113 patients undergoing total 
joint replacement surgery (table 1). All patients gave informed 
written consent prior to participation (online supplemental 
methods). Matched low- grade and high- grade OA cartilage 
samples (ie, largely intact vs degraded tissue, respectively; see 
online supplemental methods) were collected from each patient 
and synovial lining samples from 90 knee OA patients (table 1). 
All cartilage samples were collected from weight- bearing areas 
of the joint, ensuring that any differences observed between 
low- grade and high- grade OA cartilage reflected disease severity 
rather than differential mechanical loading. Cartilage scoring, 
isolation of chondrocytes and synoviocytes, and RNA extraction 
are described in online supplemental methods.
For knee OA patients, we obtained clinical characteristics and 
prescribed drugs from the electronic patient records (online 
supplemental methods).
RNA sequencing
Multiplexed libraries were sequenced on the Illumina HiSeq 
2000 or HiSeq 4000 (75bp paired- end reads). After quality 
control, we applied salmon 0.8.2,3 and tximport4 to obtain 
gene- level scaled transcripts per million estimates (online supple-
mental methods).
Molecular subgroups
We applied limma- voom5 to remove heteroscedasticity from gene 
expression data, permuted Surrogate Variable Analysis (pSVA)6 
to remove technical variation and explicitly regressed out effects 
of known sample collection and sequencing batches. We then 
applied ConsensusClusterPlus7 to identify discrete molecularly 
defined subgroups (‘clusters’) of patients, with a sensitivity anal-
ysis to verify that clustering was similar when restricting to knee 
OA patients only (online supplemental text). We tested differen-
tial gene expression between clusters using limma,8 and applied 
SPIA9 and GOseq10 to identify associated biological processes 
(online supplemental methods).
Associations between molecular clusters and clinical 
characteristics
We tested for association between cluster assignment and clin-
ical characteristics using a generalised linear model and applied 
a Bonferroni multiple- testing correction for the effective number 
of tests (p<0.0047, online supplemental methods). As sensitivity 
analyses, we successively added the following covariates to the 
models: sex, age, OA joint, body mass index (online supple-
mental methods).
In-depth characterisation of molecular heterogeneity
To test for patient heterogeneity using a method that can detect 
both discrete clustering and a continuous spectrum of variation, 
we used Multi- Omics Factor Analysis (MOFA).11 We investi-
gated the correspondence between the discrete clusters and the 
continuous spectrum of variation identified by the MOFA and 
carried out extensive sensitivity analyses to verify robustness of 
the MOFA results (online supplemental methods).
Low-grade OA cartilage classifier
We used the 'Prediction analysis for microarrays for R' (PAMR)12 
package to construct a classifier which used a smaller subset of 
genes to recapitulate the main axis of molecular heterogeneity in 
knee low- grade OA cartilage (online supplemental methods). We 
validated the classifier using an independent publicly- available 
dataset from 60 knee OA patients2 (table 1, online supplemental 
methods).
RESULTS
After quality checks, we analysed transcriptomic profiles of 259 
tissue samples from 106 patients (table 1).
Do molecular profiles in different tissues define the same 
patient subgroups?
Using consensus clustering, we identified two robust patient clus-
ters in synovium, each of which further formed two subclusters 
(figure 1A). We also identified two robust patient clusters within 
low- grade, but not high- grade OA, cartilage (figure 1B, online 
supplemental figure 1). Cartilage clustering was independent of 
the synovium clusters (Fisher’s p>0.66), and not associated with 
patient cohort nor with sequencing batches (χ2 test, p>0.96).
Signalling Pathway Impact Analysis9 showed that the differ-
ences between the two synovium patient clusters relate to 
inflammation, while differences between the sub- clusters relate 
to the extracellular matrix and to cell adhesion (figure 1C,D, 
online supplemental figure 2, table 1 and text). The differences 
between low- grade OA cartilage clusters were also strongly asso-
ciated with inflammation, extracellular matrix- related and cell 
adhesion pathways (figure 1E, online supplemental table 1).
Table 1 Characteristics of patients in discovery and validation cohorts
Variable Discovery total Discovery cohort 1 Discovery cohort 2 Discovery cohort 3 Discovery cohort 4 Validation
No of patients (after QC) 113 (106) 12 (11) 20 (17) 11 (10) 70 (68) 60 (60)
Osteoarthritis joint Knee or hip Knee Knee Hip Knee Knee
Low- grade OA cartilage samples after QC 87 11 16 10 50 60
High- grade OA cartilage samples after QC 95 10 16 10 59 –
Synovium samples after QC 77 – 16 – 61 –
Females, n (%) after QC 63 (59) 2 (19) 12 (71) 8 (73) 41 (60) 27 (45)
Age, average years (range) after QC 69 (38–88) 69 (50–88) 70 (54–79) 61 (44–88) 70 (38–84) 72 (63–85)
OA, osteoarthritis; QC, quality control.
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Figure 1 Distinct molecularly defined patient clusters identified in low- grade OA cartilage and synovium tissue. (A) Two clusters of patients based 
on consensus clustering of synovium RNA data. Each cluster formed two subclusters, with one outlier sample. (B) Two clusters of patients based 
on consensus clustering of low- grade OA cartilage RNA data. (C) Gene expression differences between synovium clusters show several significant 
(false discovery rate <5%) associations related to inflammation and osteoclast differentiation using Signalling Pathway Impact Analysis (SPIA). Here 
and below, P: p values based on enrichment of genes; perturbation of the pathway based on gene log- fold differences; or combining enrichment 
and perturbation. The associations shown are robust across several gene- level differential expression cut- offs (online supplemental table 1). (D) 
Gene expression differences between the synovium subclusters within each cluster show similar pathway associations, including to ECM–receptor 
interaction and focal adhesion pathways. (E) Gene expression differences between low- grade OA cartilage clusters show significant associations 
with inflammation and osteoclast differentiation pathways. (F) An analysis of low- grade OA cartilage samples using MOFA identifies a continuous 
spectrum of variation between samples, which corresponds to the identified clusters. Samples with intermediate MOFA factor 1 scores have lower 
Silhouette scores, showing more uncertainty in cluster assignment. For synovium, see online supplemental figure 3. ECM, extracellular matrix; FDR, 
false discovery rate; MOFA, Multi- Omics Factor Analysis; OA, osteoarthritis.
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Is the molecular subgrouping associated with clinical 
characteristics?
We found that women were more likely to be members of the 
cartilage cluster characterised by higher inflammation (OR=4.12, 
p=0.0024; online supplemental table 2 and text). Patients in the 
high- inflammation cluster were also more likely to be prescribed 
proton pump inhibitors (PPIs; OR=4.21, p=0.0040; online 
supplemental text). We did not detect significant associations 
between synovium clustering and clinical characteristics (online 
supplemental table 2 and text).
Is the molecular clustering categorical or continuous?
MOFA11 identified continuous axes of variation within synovium 
and low- grade OA cartilage tissue that correspond strongly with 
cluster assignment (figure 1F, online supplemental figures 3 
and 4, online supplementary text). In low- grade OA cartilage, 
the first MOFA factor (ie, the main axis of variation) explained 
28% of variation in gene expression levels; the gene expression 
weights for this first factor and the log- fold- differences between 
clusters had very high correlation (Pearson correlation r=0.91, 
p<10−15; online supplemental figure 4). These findings were 
also recapitulated in synovium (r 0.83–0.96 for gene weights for 
the first two MOFA factors and the log- fold- differences between 
synovium clusters and subclusters; online supplemental figure 
4). This suggests that the variation within these tissues is better 
represented as a continuous spectrum.
We verified robustness of the MOFA results using extensive 
sensitivity analyses (including restricting analysis to knee OA 
patients only or explicitly regressing out age and sex effects; 
online supplemental text).
Can a classifier reproducibly recapitulate both categorical 
clustering and the main axis of variation?
We used a soft- thresholding centroid- based method, PAMR,12 to 
construct a tool that can recapitulate the clustering and main axis 
of heterogeneity in low- grade OA cartilage. As clinical and research 
applications would likely differ between OA joints, we restricted the 
analysis to patients with knee OA. The resulting tool predicts prob-
abilities of knee low- grade OA cartilage cluster assignment based on 
the expression levels of seven genes (figure 2A, online supplemental 
figure 5, Data availability): MMP1, MMP2 and MMP13, which are 
involved in cartilage degradation13; IL6, a proinflammatory cyto-
kine; CYTL1, a cytokine- like gene, loss of which has been found to 
augment cartilage destruction in surgical OA mouse models14; APOD, 
a component of high- density lipoprotein found to be strongly upreg-
ulated by retinoic acid,15 which is in turn regulated by ALDH1A2,16 
an OA risk locus17 18 and C15orf48, of currently unknown function. 
Notably, the probabilities for cluster assignment generated by the 
classifier captured the main continuous spectrum of variation in this 
tissue (Spearman’s correlation ρ=−0.88, p<10−10; figure 2B). We 
validated the seven- gene classifier in an independent gene expression 
dataset of low- grade OA cartilage samples from 60 knee OA patients 
undergoing joint replacement surgery.2 The posterior probabilities 
for cluster assignment had good correspondence to the main contin-
uous spectrum of variation in the validation samples, supporting the 
predictive potential of the seven- gene classifier (ρ=−0.85, p<10−10; 
figure 2C).
We also found that the seven- gene classifier had improved 
generalisability compared with a classifier developed in previous 
work2: the majority of genes in the previously developed clas-
sifier showed either discordant expression differences between 
the clusters in our larger dataset or high false discovery rates 
(>30%; online supplemental table 3 and text).
DISCUSSION
Our findings indicate that molecular heterogeneity in OA carti-
lage and synovium is associated with similar biological processes 
(including inflammation), but molecularly defined patient clus-
ters differ between tissues, potentially reflecting differences in 
tissue- specific dominant disease processes.
The clustering in low- grade OA cartilage agrees with two 
previous smaller studies.1 2
We also identified an association between the cartilage high- 
inflammation cluster and female sex, which is consistent with the 
Figure 2 Clustering and main axis of variation within knee low- grade OA cartilage can be recapitulated using a seven- gene classifier. (A) PAMR 
scores for each gene in the seven- gene knee OA classifier (the difference between the standardised centroids of the two clusters) and the differential 
expression of the genes between the two low- grade OA cartilage clusters. See online supplemental figure 5 for classifier performance. (B) The PAMR 
posterior probabilities for cluster assignment are highly correlated with MOFA factor 1 scores for knee low- grade OA cartilage samples, capturing 
the main continuous spectrum of variation between samples. Inset: Spearman correlation, p<10−10. (C) In an independent set of 60 low- grade OA 
cartilage samples from 60 knee OA patients, the posterior probabilities for cluster assignment from the seven- gene classifier are well correlated with 
the continuous spectrum of variation in these samples, as quantified by the first MOFA factor in an ab initio analysis. Inset: Spearman’s correlation, 
p<10−10. IL, interleukin; MOFA, Multi- Omics Factor Analysis; OA, osteoarthritis.
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disproportionate increase in the incidence of OA in women after 
the menopause. This association might be explained by the lower 
concentration of oestrogen and androgens (which have established 
anti- inflammatory effects) in postmenopausal women.19 20 We spec-
ulate that our observed association between the high- inflammation 
cluster and PPI use could be explained by over the counter use of 
non- steroidal anti- inflammatory drugs for which PPIs are commonly 
coprescribed. We did not see discrete subgrouping in high- grade OA 
cartilage, perhaps indicating that there is less clear variation in molec-
ular profiles in cartilage with advanced degeneration.
Our MOFA results further confirmed that the main axis of vari-
ation was related to inflammation in both synovium and cartilage. 
The seven- gene classifier generated using PAMR was able to place 
knee OA patients along the inflammatory endotype axis of variation 
and confirmed that such classification reflects continuous variation 
rather than categorical clustering, with validation in independent 
data. This finding has implications for the development of thera-
peutic strategies for OA, providing empirical evidence that responses 
might be expected to be heterogeneous along an axis of variation, 
rather than discrete. However, further study will be required to 
determine to what extent the inflammation axis is present in earlier 
disease stages, is stable across time or differs with disease activity, 
which cartilage scoring system is best suited to detect this axis, and 
whether the classifier can be applied to or modified for peripheral 
tissue (eg, saliva or blood). We anticipate that, looking ahead, this 
approach could underpin tailored therapy development and help 
improve patient care.
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